SGLT2 Inhibitors Market Gains Momentum with Growing Adoption of Advanced Therapies
SGLT2 Inhibitors Market for Diabetes Treatment Market is being significantly propelled by the well-documented cardiovascular and renal protective benefits of SGLT2 inhibitors beyond glycemic management. Landmark clinical trials such as EMPA-REG OUTCOME, CANVAS, and DECLARE-TIMI 58 have demonstrated statistically significant reductions in major adverse cardiovascular events (MACE),...
0 Commenti 0 condivisioni 10 Views 0 Anteprima